
Mengchen ZHANG, Yi LI, Huiqi LIN, Tianfu YU, Fangyuan XIA, Mahanand CHATOO, Kexin LI, Honghao YU, Eviatar NEVO, Jizeng DU, Yang ZHAO, Xuequn CHEN. MDM2/X mediates reduced apoptosis in the plateau zokor: a mechanism of high-altitude adaptation[J]. Journal of Zhejiang University Science B, 2026, 27(10): 1140-1152.
@article{title="MDM2/X mediates reduced apoptosis in the plateau zokor: a mechanism of high-altitude adaptation",
author="Mengchen ZHANG, Yi LI, Huiqi LIN, Tianfu YU, Fangyuan XIA, Mahanand CHATOO, Kexin LI, Honghao YU, Eviatar NEVO, Jizeng DU, Yang ZHAO, Xuequn CHEN",
journal="Journal of Zhejiang University Science B",
volume="27",
number="10",
pages="1140-1152",
year="2026",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B2500281"
}
%0 Journal Article
%T MDM2/X mediates reduced apoptosis in the plateau zokor: a mechanism of high-altitude adaptation
%A Mengchen ZHANG
%A Yi LI
%A Huiqi LIN
%A Tianfu YU
%A Fangyuan XIA
%A Mahanand CHATOO
%A Kexin LI
%A Honghao YU
%A Eviatar NEVO
%A Jizeng DU
%A Yang ZHAO
%A Xuequn CHEN
%J Journal of Zhejiang University SCIENCE B
%V 27
%N 10
%P 1140-1152
%@ 1673-1581
%D 2026
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B2500281
TY - JOUR
T1 - MDM2/X mediates reduced apoptosis in the plateau zokor: a mechanism of high-altitude adaptation
A1 - Mengchen ZHANG
A1 - Yi LI
A1 - Huiqi LIN
A1 - Tianfu YU
A1 - Fangyuan XIA
A1 - Mahanand CHATOO
A1 - Kexin LI
A1 - Honghao YU
A1 - Eviatar NEVO
A1 - Jizeng DU
A1 - Yang ZHAO
A1 - Xuequn CHEN
J0 - Journal of Zhejiang University Science B
VL - 27
IS - 10
SP - 1140
EP - 1152
%@ 1673-1581
Y1 - 2026
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B2500281
Abstract: Murine double minute 2 (MDM2) and murine double minute 4 (MDMX) are critical for the regulation of tumor protein 53 (p53) function and apoptosis. This study compares the Mdm2/x gene sequences and functional variations of subterranean zokors from the High Plateau and the Loess Plateau. The findings reveal the molecular mechanisms by which Mdm2/x variations drive adaptation to extremely high-altitude conditions—including low oxygen, cold temperatures, and perpetual darkness in underground environments. We cloned and analyzed Mdm2/x sequences from two distinct ecological groups of subterranean rodents, Myospalax baileyi (plateau zokor) and Myospalax cansus (Gansu zokor), and reconstructed phylogenetic trees for a series of subterranean rodents and mammals, as well as the aboveground laboratory rat and humans. We found that MDM2/X in M. baileyi and M. cansus are involved in the p53-dependent low apoptosis rate, and the variations of phosphorylation sites at the C-terminus of MDM2 contribute to upregulation of p53 transcription and protein expression. We propose that gene evolutionary mechanisms enable survival under these severe combined pressures, and believe that our findings provide critical insight into how genetic modifications drive physiological resilience in Earth’s most challenging ecosystems.
[1]An X, Mao LY, Wang YJ, et al., 2024. Genomic structural variation is associated with hypoxia adaptation in high-altitude zokors. Nat Ecol Evol, 8(2):339-351.
[2]Anil B, Riedinger C, Endicott JA, et al., 2013. The structure of an MDM2-Nutlin-3a complex solved by the use of a validated MDM2 surface-entropy reduction mutant. Acta Crystallogr D Biol Crystallogr, 69(8):1358-1366.
[3]Ashur-Fabian O, Avivi A, Trakhtenbrot L, et al., 2004. Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation. Proc Natl Acad Sci USA, 101(33):12236-12241.
[4]Brummer T, Zeiser R, 2024. The role of the MDM2/p53 axis in antitumor immune responses. Blood, 143(26):2701-2709.
[5]Cai ZY, Wang LY, Song XY, et al., 2018. Adaptive transcriptome profiling of subterranean zokor, Myospalax baileyi, to high-altitude stresses in Tibet. Sci Rep, 8:4671.
[6]Cao WJ, Pu P, Wang JZ, et al., 2020. Suppressed LPS-mediated TLR4 signaling in the plateau zokor (Eospalax baileyi) compared to the bamboo rat (Rhizomys pruinosus) and rat (Rattus norvegicus). J Exp Zool Part A Ecol Integr Physiol, 333(4):240-251.
[7]Carr MI, Roderick JE, Zhang H, et al., 2016. Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice. Proc Natl Acad Sci USA, 113(52):15024-15029.
[8]Chandramohan A, Josien H, Yuen TY, et al., 2024. Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonists. Nat Commun, 15:489.
[9]Chen LH, Gilkes DM, Pan Y, et al., 2005. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. EMBO J, 24(19):3411-3422.
[10]Chen XQ, Wang SJ, Du JZ, et al., 2007. Diversities in hepatic HIF-1, IGF-I/IGFBP-1, LDH/ICD, and their mRNA expressions induced by CoCl2 in Qinghai-Tibetan plateau mammals and sea level mice. Am J Physiol Regul Integr Comp Physiol, 292(1):R516-R526.
[11]Cheng Q, Chen LH, Li ZY, et al., 2009. ATM activates p53 by regulating MDM2 oligomerization and E3 processivity. EMBO J, 28(24):3857-3867.
[12]Cheng Q, Cross B, Li BZ, et al., 2011. Regulation of MDM2 E3 ligase activity by phosphorylation after DNA damage. Mol Cell Biol, 31(24):4951-4963.
[13]Chibaya L, Karim B, Zhang H, et al., 2021. Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis. Proc Natl Acad Sci USA, 118(4):e2003193118.
[14]Coffill CR, Lee AP, Siau JW, et al., 2016. The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans. Genes Dev, 30(3):281-292.
[15]Corpet F, 1988. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res, 16(22):10881-10890.
[16]Deng XG, Wang K, Zhang SD, et al., 2014. Transcriptomatic determination of convergent evolution between plateau zokors (Eospalax baileyi) and naked mole rats (Heterocephalus glaber). Acta Theriol Sin, 34(2):129-137 (in Chinese).
[17]Efe G, Rustgi AK, Prives C, 2024. p53 at the crossroads of tumor immunity. Nat Cancer, 5(7):983-995.
[18]Fang Y, Liao GC, Yu B, 2020. Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives. Acta Pharm Sin B, 10(7):1253-1278.
[19]Gajjar M, Candeias MM, Malbert-Colas L, et al., 2012. The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage. Cancer Cell, 21:25-35.
[20]Gan Y, Wu YJ, Dong YQ, et al., 2023. The study on the impact of sex on the structure of gut microbiota of bamboo rats in China. Front Microbiol, 14:1276620.
[21]Gannon HS, Woda BA, Jones SN, 2012. ATM phosphorylation of Mdm2 Ser394 regulates the amplitude and duration of the DNA damage response in mice. Cancer Cell, 21(5):668-679.
[22]Gao CH, Li JM, Xu B, et al., 2023. Responses of blood parameters and hemoglobin subtypes in plateau zokors and plateau pikas to different altitude habitats. Acta Physiol Sin, 75(1):69-81 (in Chinese).
[23]Goldberg Z, Vogt Sionov R, Berger M, et al., 2002. Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation. EMBO J, 21(14):3715-3727.
[24]Gorbunova V, Hine C, Tian X, et al., 2012. Cancer resistance in the blind mole rat is mediated by concerted necrotic cell death mechanism. Proc Natl Acad Sci USA, 109(47):19392-19396.
[25]Guo YT, Zhang J, Xu DM, et al., 2021. Phylogenomic relationships and molecular convergences to subterranean life in rodent family Spalacidae. Zool Res, 42(5):671-674.
[26]Hashimoto T, Murata Y, Urushihara Y, et al., 2018. Severe hypoxia increases expression of ATM and DNA-PKcs and it increases their activities through Src and AMPK signaling pathways. Biochem Biophys Res Commun, 505(1):13-19.
[27]Holehouse AS, Kragelund BB, 2024. The molecular basis for cellular function of intrinsically disordered protein regions. Nat Rev Mol Cell Biol, 25(3):187-211.
[28]Hu YB, Wang XP, Xu YC, et al., 2023. Molecular mechanisms of adaptive evolution in wild animals and plants. Sci China Life Sci, 66(3):453-495.
[29]Karakostis K, Malbert-Colas L, Thermou A, et al., 2024. The DNA damage sensor ATM kinase interacts with the p53 mRNA and guides the DNA damage response pathway. Mol Cancer, 23:21.
[30]Levine AJ, 2020. p53:800 million years of evolution and 40 years of discovery. Nat Rev Cancer, 20:471-480.
[31]Liu X, Zhang SZ, Cai ZY, et al., 2022. Genomic insights into zokors’ phylogeny and speciation in China. Proc Natl Acad Sci USA, 119(19):e2121819119.
[32]Medina-Medina I, García-Beltrán P, de la Mora-de la Mora I, et al., 2016. Allosteric interactions by p53 mRNA govern HDM2 E3 ubiquitin ligase specificity under different conditions. Mol Cell Biol, 36(16):2195-2205.
[33]Olcina MM, Grand RJ, Hammond EM, 2014. ATM activation in hypoxia - causes and consequences. Mol Cell Oncol, 1(1):e29903.
[34]Oren M, Prives C, 2024. p53: a tale of complexity and context. Cell, 187(7):1569-1573.
[35]Padariya M, Jooste ML, Hupp T, et al., 2022. The elephant evolved p53 isoforms that escape MDM2-mediated repression and cancer. Mol Biol Evol, 39(7):msac149.
[36]Pant V, Lozano G, 2014. Limiting the power of p53 through the ubiquitin proteasome pathway. Genes Dev, 28(16):1739-1751.
[37]Peuget S, Zhou XL, Selivanova G, 2024. Translating p53-based therapies for cancer into the clinic. Nat Rev Cancer, 24:192-215.
[38]Shao Y, Li JX, Ge RL, et al., 2015. Genetic adaptations of the plateau zokor in high-elevation burrows. Sci Rep, 5:17262.
[39]Shi Y, Liu Z, Zhang Q, et al., 2020. Phosphorylation of seryl-tRNA synthetase by ATM/ATR is essential for hypoxia-induced angiogenesis. PLoS Biol, 18(12):e3000991.
[40]Tan BX, Liew HP, Chua JS, et al., 2017. Anatomy of Mdm2 and Mdm4 in evolution. J Mol Cell Biol, 9(1):3-15.
[41]Tuval A, Strandgren C, Heldin A, et al., 2024. Pharmacological reactivation of p53 in the era of precision anticancer medicine. Nat Rev Clin Oncol, 21:106-120.
[42]Wang C, Zhang YJ, Chen WJ, et al., 2024. New-generation advanced PROTACs as potential therapeutic agents in cancer therapy. Mol Cancer, 23:110.
[43]Wang W, Albadari N, Du Y, et al., 2024. MDM2 inhibitors for cancer therapy: the past, present, and future. Pharmacol Rev, 76(3):414-453.
[44]Wei DB, Wei L, Zhang JM, et al., 2006. Blood-gas properties of plateau zokor (Myospalax baileyi). Comp Biochem Physiol Part A Mol Integr Physiol, 145(3):372-375.
[45]Wei YY, Zhang T, Li ZF, et al., 2025. Evolutionary divergence on the Qinghai–Xizang Plateau: how life-history traits shape the diversity of plateau zokor and pika populations. J Genet Genomics, 52(9):1096-1108.
[46]Wu KKL, Xu XF, Wu MY, et al., 2024. MDM2 induces pro-inflammatory and glycolytic responses in M1 macrophages by integrating iNOS-nitric oxide and HIF-1α pathways in mice. Nat Commun, 15:8624.
[47]Xiao KP, Liang XH, Lu HR, et al., 2022. Adaptation of gut microbiome and host metabolic systems to lignocellulosic degradation in bamboo rats. ISME J, 16(8):1980-1992.
[48]Yu ZQ, Zhang EE, 2023. Disrupted circadian rhythms in the plateau pika. Trends Neurosci, 46(12):1005-1007.
[49]Zhang NY, Hou DY, Hu XJ, et al., 2023. Nano proteolysis targeting chimeras (PROTACs) with anti-hook effect for tumor therapy. Angew Chem Int Ed, 62(37):e202308049.
[50]Zhang ST, Zhao Y, Hu XF, et al., 2013. Distinct post-transcriptional regulation of Igfbp1 gene by hypoxia in lowland mouse and Qinghai-Tibet plateau root vole Microtus oeconomus. Mol Cell Endocrinol, 376(1-2):33-42.
[51]Zhang T, Lei ML, Zhou H, et al., 2022. Phylogenetic relationships of the zokor genus Eospalax (Mammalia, Rodentia, Spalacidae) inferred from whole-genome analyses, with description of a new species endemic to Hengduan Mountains. Zool Res, 43(3):331-342.
[52]Zhang XY, Khakisahneh S, Liu W, et al., 2023. Phylogenetic signal in gut microbial community rather than in rodent metabolic traits. Natl Sci Rev, 10:nwad209.
[53]Zhao Y, Ren JL, Wang MY, et al., 2013. Codon 104 variation of p53 gene provides adaptive apoptotic responses to extreme environments in mammals of the Tibet plateau. Proc Natl Acad Sci USA, 110(51):20639-20644.
[54]Zhao Y, Tang JW, Yang Z, et al., 2016. Adaptive methylation regulation of p53 pathway in sympatric speciation of blind mole rats, Spalax. Proc Natl Acad Sci USA, 113(8):2146-2151.
CLC number:
On-line Access: 2026-10-23
Received: 2025-05-27
Revision Accepted: 2025-09-10
Crosschecked: 0000-00-00
Cited: 0
Clicked: 3628
Citations: Bibtex RefMan EndNote GB/T7714
Open peer comments: Debate/Discuss/Question/Opinion
<1>